# ClinicalTrials.gov record NCT05845749

> PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct05845749-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05845749-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05845749-vosoritide-v1.json
- Content SHA-256: `7b7e72b5a3c43de6ff9acaea01c987aa19db78458698c888fe588a36a9655a09`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05845749 ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

## Sources

<a id="source-ctg-observation-nct05845749-2026-03-10-44c431af1724"></a>
- **ClinicalTrials.gov record NCT05845749 · retained source version 2026-03-10:44c431af17249d0c6ab44ea2311d816edfaec20ccfe4e9a084e561b2e5fc4a07** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05845749) (`ctg-observation-nct05845749-2026-03-10-44c431af1724`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05845749." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05845749-vosoritide-v1.json SHA-256: 7b7e72b5a3c43de6ff9acaea01c987aa19db78458698c888fe588a36a9655a09.